US Food and Drug Administration set to approve Pfizer COVID vaccine for adolescents ages 12 to 15 early next week
Updated May 04, 2021;
The U.S. Food and Drug Administration is expected to approve the Pfizer-BioNTech COVID-19 vaccine for use in adolescents between the ages of 12 and 15 early next week, according to the New York Times.
Following its emergency use authorization, the Centers for Disease Control and Prevention’s federal vaccine advisory committee will convene to review the clinical trial data and make a formal recommendation for the vaccine’s use in 12- to 15-year-olds. Shots could begin within a matter of days after the CDC adopts the committee’s recommendation.
COVID-19 vaccines could soon be approved for some children under the age of 16, and two teenage siblings from Massachusetts took part in those trials.Zoe Campbell, 15, and Esme Campbell, 13, participated in Cambridge-based Moderna s child COVID-19 vaccine trials back in March, and Esme was just 12 when she participated. I thought it would be really cool if I could be one of the people contributing to making the vaccine available for kids, Esme Campbell said. I was just really excited because with the pandemic, a lot has felt out of my control, and I ve been looking forward to the vaccine for about a year now, Zoe Campbell said.The girls father, Dr. Justin Campbell of South Shore Health, says he and his wife, Dr. Lucy Chie of Beth Israel Deaconess Medical Center, did their research on the COVID-19 vaccine and that they all made a decision as a family. We didn t want to force our kids into doing it, Dr. Campbell said. We did feel like it was very likely safe. The Pfizer COVID
Federal panel recommends continued âpauseâ on J&J vaccine until rare blood clots better understood Doctors hope to resolve safety issues in week to 10 days
By Jonathan Saltzman Globe Staff,Updated April 14, 2021, 1 hour ago
Email to a Friend
A health care worker prepared a dose of the Johnson & Johnson vaccine early this month.Mark Kauzlarich/Bloomberg
Beset with unanswered questions, a federal advisory committee agreed Wednesday that use of Johnson & Johnsonâs COVID-19 vaccine should not resume in the United States until they get more information about a possible link between the shot and rare but severe blood clots in women under 50.
Johnson & Johnson To Test Its COVID Vaccine On Kids Ages 12 To 17 msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.